Multiple Myeloma Research Foundation Makes Changes in Leadership to Advance Precision Medicine
The Multiple Myeloma Research Foundation (MMRF) is growing…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Partners to Develop and Market TNB-383B Antibody for Multiple Myeloma
The development and commercialization of TNB-383B — an anti-BCMA antibody…
Split Dosing of Darzalex Over Consecutive Days Approved by FDA for Multiple Myeloma Patients
The U.S. Food and Drug Administration has approved a…
$75M Gift to Establish Center for Blood Cancers at NYU Langone Health Center
Owing to an anonymous $75 million gift, New…
Real-world Data Supports Use of Oral Triple Combination in Treating Advanced Multiple Myeloma, Study Finds
Real world data from multiple myeloma patients in Hungary…
Isatuximab Extends Time Without Cancer Progression in Phase 3 Trial of Multiple Myeloma
Adding isatuximab to a standard of care treatment…
